Loading...
XCNQ
IAN
Market cap24mUSD
Sep 17, Last price  
0.01CAD
1D
0.00%
1Q
0.00%
Jan 2017
-99.79%
IPO
-99.66%
Name

Ianthus Capital Holdings Inc

Chart & performance

D1W1MN
XCNQ:IAN chart
P/E
P/S
0.17
EPS
Div yield, %
Shrs. gr., 5y
108.12%
Rev. gr., 5y
-1.03%
Revenues
144m
-14.07%
045,566391,6522,407,2293,405,28978,382,000151,669,000203,018,000163,213,000159,237,000167,567,000143,986,000
Net income
-41m
L+435.71%
-1,564,952-1,315,748-5,055,732-13,716,665-71,475,664-301,254,000-310,031,000-76,248,000-449,391,000-76,621,000-7,636,000-40,906,774
CFO
3m
-74.92%
0-1,259,611-3,284,783-6,493,189-29,010,984-45,849,000-13,074,00016,148,000-19,496,0003,017,00012,544,0003,146,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

iAnthus Capital Holdings, Inc. is a U.S.-based cannabis enterprise that holds licenses for and actively manages cannabis cultivation, processing, and retail dispensary operations. Its diverse product portfolio encompasses both cannabis and cannabidiol (CBD) offerings. For cannabis, these include traditional biomass items like pre-rolls, various infused products such as edibles and topical creams, and a wide array of concentrates and vapeables, specifically live resins, waxes, oils, tinctures, and vape cartridges. The CBD line features topical creams, tinctures, and sprays, alongside a comprehensive range of beauty and skincare solutions, including lotions, haircare items, lip balms, and bath bombs. Beyond direct retail, the company also engages in wholesale distribution of its CBD product selection. Operationally, iAnthus maintains a significant presence, controlling or operating 32 retail dispensaries and 10 cultivation or processing facilities across eight states. Established in 2014, its corporate headquarters are located in New York, New York.

Related entities

Subsidiaries
MPX Bioceutical ULC

Key people

Randy Maslow
President, Director · since 2016
Hadley C. Ford
Chief Executive Officer, Director · since 2016
Pat Tiernan
Chief Operating Officer · since 2019
Todd Karnig
Senior Vice President - Western Operations
Neil Calvesbert
Chief Marketing Officer
Ray Chevalier
Vice President - Infrastructure
Richard J. Boxer
Chief Medical Officer · since 2016
Robert R. Galvin
Director · since 2019
Julius John Kalcevich
Chief Financial Officer, Corporate Secretary, Director · since 2016
Director · since 2019
Chief Strategy Officer and Director · since 2019
IPO date
Sep 07, 2016
Employees
840
Domiciled in
US
Incorporated in
CA
Headquarters & legal address
Suite 2740, 22 Adelaide Street West, East Tower, Bay Adelaide Centre
Toronto, ON M5H 4E3
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT